TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT03887715: A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Con

Sponsor: LivaNova · Phase: PHASE2 · Area: CNS_NEUROLOGY · Target Enrollment: 6800 pts

Competing Trials Overlap

14 Active Trials

Excess Burn Exposure

$12,416,000

Rescue Site Savings

+$8,186,800

Unlock Full NCT03887715 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT03887715 Rescue Dossier →